To the full analysis
Buyback calculator for Biogen
Biogen stock: key metrics
BIIBBiogen had an operating margin of 19.1% and a return on invested capital (ROIC) of 8.2% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 89.8% | 16.4% | 8.1% |
| 2007 | 89.4% | 24.6% | 20.1% |
| 2008 | 90.2% | 29.6% | 19.1% |
| 2009 | 91.3% | 29.6% | 22.2% |
| 2010 | 91.5% | 26.5% | 21.3% |
| 2011 | 90.8% | 34.2% | 24.5% |
| 2012 | 90.1% | 33.3% | 25.0% |
| 2013 | 87.6% | 36.3% | 26.9% |
| 2014 | 87.9% | 40.9% | 30.2% |
| 2015 | 88.5% | 45.4% | 33.0% |
| 2016 | 87.5% | 45.0% | 32.3% |
| 2017 | 86.7% | 43.6% | 20.7% |
| 2018 | 86.5% | 43.8% | 32.9% |
| 2019 | 86.4% | 49.0% | 41.0% |
| 2020 | 86.6% | 34.2% | 29.8% |
| 2021 | 80.8% | 25.4% | 14.2% |
| 2022 | 77.6% | 28.4% | 29.9% |
| 2023 | 74.2% | 21.3% | 11.8% |
| 2024 | 76.1% | 25.7% | 16.9% |
| 2025 | 70.5% | 19.1% | 13.2% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 3.0% | 3.5% | 2.5% |
| 2007 | 11.5% | 8.9% | 7.4% |
| 2008 | 13.5% | 14.5% | 9.2% |
| 2009 | 15.6% | 16.3% | 11.3% |
| 2010 | 18.6% | 15.8% | 12.4% |
| 2011 | 19.2% | 22.7% | 13.6% |
| 2012 | 19.8% | 22.5% | 13.6% |
| 2013 | 21.6% | 26.4% | 15.7% |
| 2014 | 27.1% | 33.9% | 20.5% |
| 2015 | 37.8% | 33.6% | 18.2% |
| 2016 | 30.5% | 29.4% | 16.2% |
| 2017 | 20.1% | 19.5% | 10.7% |
| 2018 | 34.0% | 29.5% | 17.5% |
| 2019 | 44.1% | 38.4% | 21.6% |
| 2020 | 37.4% | 23.7% | 16.3% |
| 2021 | 14.3% | 17.7% | 6.5% |
| 2022 | 22.7% | 15.9% | 12.4% |
| 2023 | 7.8% | 10.4% | 4.3% |
| 2024 | 9.8% | 10.1% | 5.8% |
| 2025 | 7.1% | 8.2% | 4.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 30 Jun 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.